Target intelligence / Profile preview

Cutibacterium acnes proteins and lipids

Molecular classification
Enzyme, Lipid, Other bacterial protein, Metabolite
01

Overview

The proteins and lipids produced by Cutibacterium acnes comprise a diverse group of molecules central to the bacterium’s adaptation to human skin and its role in health and disease. Key proteins include multiple lipases, such as triacylglycerol lipase GehA and GehB, which degrade sebum triglycerides into free fatty acids, modulating skin pH and inflammation and contributing to acne pathogenesis[9]. The lipid profile includes triglycerides, ceramides, phosphatidylcholine, sphingomyelins, cardiolipins, and fatty acid amides, with unique lipids serving as potential strain markers for diagnostics and epidemiology[4][2][5]. Bacterial metabolites such as propionic acid shape both the microbiome and epidermal lipid synthesis, enhancing barrier function but also promoting colonization and sometimes inflammation[1][3][7]. Both proteins and lipids can serve as antigens, modulate host immunity, and have therapeutic and diagnostic significance in skin diseases and infections. If a more specific molecular target is required, “Cutibacterium acnes triacylglycerol lipase (GehA)” or “Cutibacterium acnes ceramide” would be preferred canonical entries[9][2][5].

Other names
Propionibacterium acnes proteins and lipidsC. acnes proteins and lipidsP. acnes proteins and lipidsAcne-associated bacterial proteins and lipids
02

Mechanism of action

Enzyme inhibition (inhibition of lipase activity to prevent lipid degradation and FFA-driven inflammation) Bactericidal action (antibiotics disrupt bacterial cell wall or protein synthesis) Modulation of lipid metabolism (drugs that alter keratinocyte lipid synthesis, affecting colonization and barrier function)

03

Biological functions

Lipid metabolismImmune responseCell adhesion and colonizationSkin barrier functionPathogenesis of inflammationAntimicrobial activity
04

Disease associations

InfectionInflammationOther
05

Safety considerations

Antibiotic resistanceNon-specific targetingInflammation riskBiofilm formation
06

Interacting drugs

Antibiotics

3 more in the full profile.

07

Biomarkers

C. acnes phylotype-specific lipidsLipase expression/gehalasesShort-chain fatty acids

Beyond the preview

Go deeper on Cutibacterium acnes proteins and lipids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cutibacterium acnes proteins and lipids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call